• Reframe Daily
  • Posts
  • Reframe Daily: Nose spray for faster healing and a nasal HPV cancer vaccine in the lab

Reframe Daily: Nose spray for faster healing and a nasal HPV cancer vaccine in the lab

Scientists tested a love-hormone nose spray, pre-surgery “training,” sound-wave brain openings, gene fixes for hearing loss, and a nasal HPV cancer vaccine—each pushing healing and cancer control forward in new ways.

Reframe Daily—curated by Christin Chong (neuroscience PhD, Buddhist chaplain, healthtech strategy consultant)—delivers optimistic and credible health research updates you won’t find in most popular news outlets, from sources scientists and healthcare providers read and trust.

Today in one sentence: Doctors showed that getting your body ready before big surgery can boost healing, a nose spray with the “love hormone” helped skin wounds heal faster, sound waves safely opened the brain’s barrier in kids with tough tumors so medicines can get in, tiny bubbles carried gene fixes that restored hearing in deaf mice, and a needle-free nasal HPV vaccine stopped cervical cancers from growing in animals.

Pop in the Discord to chat about health
https://forms.gle/tN3oabFTsDF21VnS8

Personal shares from Christin here
http://christin.substack.com/

Good news: A simple, tailored “prehab” plan (exercise, nutrition, and stress‑management tuned to each person) before major surgery helped the body’s immune system get ready to heal. That can mean smoother recovery for many patients. 

Market readiness: 🙂🙂🙂🙂🙂 (hospitals can implement now using readily available programs; no new drug or device needed).

Good news: A nose spray of oxytocin, paired with simple positive partner interactions, sped up skin wound healing and eased stress signals in a randomized trial. It points to a low‑burden way to help everyday healing. 

Market readiness: 🙂🙂🙂 (early clinical study; oxytocin nasal formulations exist via compounding, but not FDA‑approved for this use—needs larger trials).

Good news: Doctors safely opened the blood–brain barrier in kids with diffuse midline glioma (a hard‑to‑treat brain cancer) using neuronavigation‑guided focused ultrasound. This could let more medicine reach tumors that drugs usually can’t get to. (Cancer #1 of 2) 

Market readiness: 🙂🙂🙂 (first‑in‑/early‑human feasibility; ultrasound platforms exist but not cleared for this indication—requires larger efficacy trials).

Good news: Researchers used tiny, cell‑made vesicles to deliver CRISPR gene‑editing tools and improve hearing in adult mice with a progressive inherited deafness. It’s a gentler, non‑viral way that could make future ear gene therapies safer. 

Market readiness: 🙂 (preclinical in mice; multiple steps before human trials).

Good news: A needle‑free, nasal therapeutic HPV vaccine—built on a cationic nanogel—blocked the development of cervical cancer in animal models. It hints at a future, non‑invasive cancer treatment to pair with screening. (Cancer #2 of 2) 

Market readiness: 🙂 (preclinical in animals; will need human safety and efficacy trials).

Thank you for taking the time to take care of yourself and your loved ones.